RTALB.E — RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS Share Price
Last trade - 00:00- TRY1.23bn
- TRY1.14bn
- TRY86.03m
- 31
- 32
- 38
- 23
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.35 | ||
| Price to Tang. Book | 1.35 | ||
| Price to Free Cashflow | 46.93 | ||
| Price to Sales | 18.39 | ||
| EV to EBITDA | 126.11 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 1.32% | ||
| Return on Equity | 32.53% | ||
| Operating Margin | 18.59% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | TRYm | 20.47 | 16.77 | 230.44 | 384.34 | 86.03 | n/a | n/a | 17.48% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +15.77 | -12.4 | +1247.57 | +29.26 | +132.18 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS is a Turkey-based company engaged in the research, development and production of in vitro diagnostics. Its diagnostic products include: Clinical Microbiology, such as chromogenic media, culture media in petri dishes, tubes and bottles, rodac petri surcheck, and tuberculosis diagnosis products; ELISA Kits, such as HBsAg ELISA Kit; Molecular Diagnostics, such as nucleic acid isolation kits, real-time PCR instruments, real-time PCR kits and RTA VOLTRAN voral detection system, as well as other tests. Its Research includes: dehydrated culture media, such as dehydrated chromogenic culture media; nucleic acid isolation kits and real-time PCR.
Directors
- Resat Ultav CHM
- Ali Tas VCH
- Guven Akat FID
- Bahadir Akdemir VRD
- Bilgen Yusufoglu DGM
- Ahmet Baris DSL
- Arzu Gunaydin DSL
- Sinan Levent DSL
- Alev Kahraman OTH
- Gokhan Celikelli DRC
- M. Tayyip Turkaslan DRC
- Tahsin Yesildere DRC
- Last Annual
- December 31st, 2022
- Last Interim
- September 30th, 2023
- Incorporated
- May 13th, 1996
- Public Since
- June 2nd, 2014
- No. of Employees
- 54
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Istanbul Stock Exchange
- Shares in Issue
- 100,000,000
- Address
- KOCAELI, 41400
- Web
- https://rtalabs.com.tr
- Phone
- +90 2626485300
- Auditors
- PKF International
Upcoming Events for RTALB.E
Similar to RTALB.E
Deva Holding AS
Istanbul Stock Exchange
EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS
Istanbul Stock Exchange
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS
Istanbul Stock Exchange
Selcuk Ecza Deposu Ticaret ve Sanayi AS
Istanbul Stock Exchange
Turk Ilac ve Serum Sanayi AS
Istanbul Stock Exchange
FAQ
As of Today at 19:18 UTC, shares in RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS are trading at TRY12.25. This share price information is delayed by 15 minutes.
Shares in RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS last closed at TRY12.25 and the price had moved by +53.32% over the past 365 days. In terms of relative price strength the RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS share price has outperformed the FTSE Global All Cap Index by +41.42% over the past year.
There is no consensus recommendation for this security.
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS does not currently pay a dividend.
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS does not currently pay a dividend.
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS does not currently pay a dividend.
To buy shares in RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of TRY12.25, shares in RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS had a market capitalisation of TRY1.23bn.
Here are the trading details for RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS:
- Country of listing: Turkey
- Exchange: IST
- Ticker Symbol: RTALB.E
Based on an overall assessment of its quality, value and momentum RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -32.45%.
As of the last closing price of TRY12.25, shares in RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS were trading -12.06% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at TRY12.25.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS' management team is headed by:
- Resat Ultav - CHM
- Ali Tas - VCH
- Guven Akat - FID
- Bahadir Akdemir - VRD
- Bilgen Yusufoglu - DGM
- Ahmet Baris - DSL
- Arzu Gunaydin - DSL
- Sinan Levent - DSL
- Alev Kahraman - OTH
- Gokhan Celikelli - DRC
- M. Tayyip Turkaslan - DRC
- Tahsin Yesildere - DRC